C-MER Medical Holdings Limited (stock code: 03309) disclosed that on 16 February 2026, it repurchased 150,000 ordinary shares on the Hong Kong Stock Exchange at HKD 1.49 per share. The buyback represented approximately 0.0124% of the company’s issued shares (excluding treasury shares) and involved a total cost of HKD 223,500. Following the transaction, the number of treasury shares increased from 20.14 million to 20.29 million, while the total issued shares remained at 1.23 billion, with 1.21 billion shares excluding treasury shares.

According to the announcement, the repurchase was conducted under a mandate passed on 19 May 2025, which authorizes a total repurchase of up to 125.56 million shares. As of the transaction date, the repurchased shares constituted 0.0119% of the total issued shares (excluding treasury shares) under that mandate.